Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity

Autoimmunity represents a broad category of diseases that involve a variety of organ targets and distinct autoantigens. For patients with autoimmune diseases who fail to respond to approved disease-modifying treatments, autologous hematopoietic stem cell transplantation (AHSCT) after high-dose immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Kristina M., Lu, Tingting, Lim, Noha, Turka, Laurence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801415/
https://www.ncbi.nlm.nih.gov/pubmed/29456529
http://dx.doi.org/10.3389/fimmu.2018.00100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801415/
https://www.ncbi.nlm.nih.gov/pubmed/29456529
http://dx.doi.org/10.3389/fimmu.2018.00100

Ejemplares similares